Pharmacoeconomics of Influenza Vaccination in the Elderly
- 1 September 2000
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 17 (3) , 217-227
- https://doi.org/10.2165/00002512-200017030-00005
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Influenza Vaccination in 29 CountriesPharmacoEconomics, 1999
- Economic Evaluation of Influenza VaccinationPharmacoEconomics, 1999
- Real World Designs in Economic EvaluationPharmacoEconomics, 1999
- Interpretation of cost-effectiveness analysesJournal of General Internal Medicine, 1998
- The impact of age on cost-effectiveness ratios and its control in decision makingHealth Economics, 1996
- Economic Evaluation of Vaccination Against Influenza in New ZealandPharmacoEconomics, 1996
- French Economic Evaluations of Influenza and Influenza VaccinationPharmacoEconomics, 1996
- Evaluating the Impact of Influenza VaccinationPharmacoEconomics, 1996
- Cost-effectiveness league tables: More harm than good?Social Science & Medicine, 1993
- Review of Cost-Benefit Analyses of Influenza VaccinePharmacoEconomics, 1992